A novel selective multi-targeted tyrosine kinase inhibitor with superior anti-tumor efficacy

被引：0
|
作者：
Hjarnaa, P. [1 ]
Fensholdt, Jef [1 ]
机构：
[1] LEO Pharma AS, Ballerup, Denmark
来源：
INFLAMMATION RESEARCH | 2007年 / 56卷
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
引用
收藏
页码：S464 / S465
页数：2
相关论文
共 50 条
  • [1] Combining novel STAT3 inhibitor YHO-1701 with multi-targeted tyrosine kinase inhibitor sorafenib improves anti-tumor response in solid tumor xenograft model
    Taniguchi, K.
    Nishisaka, F.
    Tsugane, M.
    Hirata, G.
    Takagi, A.
    Ishii, S.
    Takahashi, H.
    Iijima, T.
    Asai, A.
    Matsuzaki, T.
    Shishido, Y.
    EUROPEAN JOURNAL OF CANCER, 2018, 103 : E38 - E39
  • [2] Multi-targeted tyrosine kinase inhibitor sunitinib: a novel strategy for sporadic malignant pheochromocytoma
    Sun Fu-kang
    He Hong-chao
    Su Ting-wei
    Zhou Wen-long
    Huang Xin
    Dai Jun
    Shen Zhou-jun
    CHINESE MEDICAL JOURNAL, 2012, 125 (12) : 2231 - 2234
  • [3] Battling Glioblastoma: A Novel Tyrosine Kinase Inhibitor with Multi-Dimensional Anti-Tumor Effect
    Viswanathan, Anisha
    Musa, Aliyu
    Murugesan, Akshaya
    Vale, Joao R.
    Afonso, Carlos A. M.
    Mani, Saravanan Konda
    Yli-Harja, Olli
    Candeias, Nuno R.
    Kandhavelu, Meenakshisundaram
    CELLS, 2019, 8 (12)
  • [4] TKI258, a novel, multi-targeted tyrosine kinase inhibitor for the treatment of breast cancer
    Liu, Hongyu
    Dieing, Annette
    Lehenbauer-Dehm, Sylvia
    Kuehnhardt, Dagmar
    Regierer, Anne
    Schulz, Carsten
    Storek, Benjamin
    Schwarck, Sandra
    Possinger, Kurt
    Eucker, Jan
    CANCER RESEARCH, 2009, 69
  • [5] E7080, a multi-targeted tyrosine kinase inhibitor suppresses tumor cell migration and invasion
    Hilary Glen
    Susan Mason
    Hitesh Patel
    Kenneth Macleod
    Valerie G Brunton
    BMC Cancer, 11
  • [6] E7080, a multi-targeted tyrosine kinase inhibitor suppresses tumor cell migration and invasion
    Glen, Hilary
    Mason, Susan
    Patel, Hitesh
    Macleod, Kenneth
    Brunton, Valerie G.
    BMC CANCER, 2011, 11
  • [7] A multi-targeted tyrosine kinase inhibitor lenvatinib for the treatment of mice with advanced glioblastoma
    Li, Jia
    Zou, Chang-Lin
    Zhang, Zhi-Ming
    Lv, Lian-Jie
    Qiao, Hai-Bo
    Chen, Xiu-Ju
    MOLECULAR MEDICINE REPORTS, 2017, 16 (05) : 7105 - 7111
  • [8] Analysis of sunitinib malate, a multi-targeted tyrosine kinase inhibitor: A critical review
    AboulMagd, Asmaa M.
    Abdelwahab, Nada S.
    MICROCHEMICAL JOURNAL, 2021, 163
  • [9] Tyrosine kinase inhibitors: Multi-targeted or single-targeted?
    Broekman, Fleur
    Giovannetti, Elisa
    Peters, Godefridus J.
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2011, 2 (02): : 80 - 93
  • [10] Anti-tumor effects of SU11248, an oral multi-targeted receptor tyrosine kinase inhibitor, given alone or in combination with cetuximab and/or docetaxel in hormone refractory prostate cancer
    Guerin, Olivier
    Formento, Patricia
    Hofman, Paul
    Fischel, Jean-Louis
    Etienne, Marie-Christine
    Milano, Gerard A.
    CANCER RESEARCH, 2006, 66 (08)
12345